The CaPP3 study opened to recruitment at the Institute of
Genetic Medicine, Newcastle on Wednesday 1st October 2014.
Professor Sir John Burn consented the first recruit.
The first batch of packed aspirin has been delivered to the
pharmacy in Newcastle ready for dispensing.
The study will be recruiting through all the UK Regional
Genetics Centres. Over the next few months these centres too will
be opening to recruitment, once they have completed their local
So after several long years of working our way through UK
regulatory processes the CaPP3 study is finally open to
LYNCH syndrome is deadly but new tests and treatment could help
identify and beat it, says campaigner and bowel cancer survivor
Lynn Faulds Wood.
Read the full article on the